Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001198734 | SCV001369729 | pathogenic | Usher syndrome type 1D | 2019-11-27 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP3. |
Labcorp Genetics |
RCV001381510 | SCV001579942 | pathogenic | not provided | 2024-11-03 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu363Trpfs*58) in the PCDH15 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PCDH15 are known to be pathogenic (PMID: 11398101, 11487575, 14570705). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 11487575). ClinVar contains an entry for this variant (Variation ID: 4932). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003472980 | SCV004200797 | pathogenic | Autosomal recessive nonsyndromic hearing loss 23 | 2024-03-30 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005041989 | SCV005677170 | pathogenic | Autosomal recessive nonsyndromic hearing loss 23; Usher syndrome type 1D; Usher syndrome type 1F | 2024-05-03 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000005217 | SCV000025395 | pathogenic | Usher syndrome type 1F | 2012-10-05 | no assertion criteria provided | literature only |